Bill Miller Alaunos Therapeutics, Inc. Transaction History

Miller Value Partners, LLC

$177 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.44 - $2.73 $14.9 Million - $28.2 Million	-10,317,698 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.63 - $3.67 $3.99 Million - $5.57 Million	-1,516,969 Reduced 12.82%	10,317,698 $27.2 Million
Q1 2021 May 17, 2021	SELL	$2.82 - $5.6 $1.78 Million - $3.54 Million	-631,581 Reduced 5.07%	11,834,667 $42.6 Million
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $168,583 - $249,245	80,662 Added 0.65%	12,466,248 $31.4 Million
Q3 2020 Nov 16, 2020	SELL	$2.39 - $3.43 $559,604 - $803,113	-234,144 Reduced 1.86%	12,385,586 $31.2 Million
Q2 2020 Aug 14, 2020	SELL	$2.2 - $3.71 $522,071 - $880,401	-237,305 Reduced 1.85%	12,619,730 $41.4 Million
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $233,320 - $611,544	122,800 Added 0.96%	12,857,035 $31.5 Million
Q4 2019 Feb 14, 2020	SELL	$3.95 - $5.35 $983,198 - $1.33 Million	-248,911 Reduced 1.92%	12,734,235 $60.1 Million
Q3 2019 Nov 14, 2019	BUY	$4.13 - $6.94 $15.5 Million - $26 Million	3,743,996 Added 40.52%	12,983,146 $55.6 Million
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $51,100 - $112,420	-25,550 Reduced 0.28%	9,239,150 $35.6 Million
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $7.16 Million - $16.1 Million	4,447,154 Added 92.31%	9,264,700 $16.6 Million
Q3 2018 Nov 14, 2018	SELL	$2.26 - $3.27 $224,022 - $324,138	-99,125 Reduced 2.02%	4,817,546 $15.4 Million
Q2 2018 Aug 14, 2018	SELL	$3.02 - $4.94 $366,250 - $599,098	-121,275 Reduced 2.41%	4,916,671 $14.8 Million
Q1 2018 May 15, 2018	SELL	$3.46 - $5.14 $160,198 - $237,981	-46,300 Reduced 0.91%	5,037,946 $19.7 Million
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $903,560 - $1.48 Million	225,890 Added 4.65%	5,084,246 $21 Million
Q3 2017 Nov 14, 2017	BUY	$4.99 - $6.57 $24.2 Million - $31.9 Million	4,858,356	4,858,356 $29.8 Million

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $517M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track Bill Miller's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Miller Value Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miller Value Partners, LLC and Bill Miller with notifications on news.

Account